Clinical Prediction Scores for Suspected Meningitis
Yes, there are validated clinical prediction scores for suspected meningitis, with the Bacterial Meningitis Score (BMS) being the most extensively validated tool that can safely rule out bacterial meningitis when the score is 0.
The Bacterial Meningitis Score (BMS)
The BMS is a validated clinical prediction rule that identifies patients at very low risk for bacterial meningitis based on five high-risk criteria 1:
- Positive CSF Gram stain
- CSF protein ≥80 mg/dL
- CSF absolute neutrophil count (ANC) ≥1,000 cells/mm³
- Peripheral blood ANC ≥10,000 cells/mm³
- Seizure at or prior to presentation
Patients with NONE of these criteria (BMS = 0) are at very low risk for bacterial meningitis.
Performance in Different Populations
In adults: The BMS demonstrates excellent performance with sensitivity of 100% (95% CI: 40-100%), specificity of 51% (95% CI: 46-56%), and negative predictive value of 100% (95% CI: 98-100%) 1. A more recent multicenter study in adults confirmed a negative predictive value of 99.5% (95% CI: 97.4-100) with only one bacterial meningitis case missed among patients with BMS = 0 2.
In children: Multiple validation studies confirm the BMS performs well in pediatric populations aged ≥28 days, with AUCs ranging from 0.74 to 0.96 (median 0.89) 3. However, performance is lower in neonates with AUCs ranging from 0.58 to 0.91 (median 0.79) 3.
Clinical Utility
When applied prospectively, the BMS could reduce hospital admission rates from 84% to 49% without missing bacterial meningitis cases 1. The score showed potential to avoid 64.1% (95% CI: 57.3-70.3) of unnecessary meningeal-dose antibiotic treatments 2.
Alternative Scoring Systems
Meningitis Score for Emergencies (MSE)
This pediatric prediction rule assigns points as follows 4:
- 3 points: Procalcitonin >1.2 ng/dL
- 2 points: CSF protein >80 mg/dL
- 1 point each: CRP >40 mg/L and CSF ANC >1,000 cells/mm³
A score ≥3 showed optimal performance with sensitivity of 92.86% (95% CI: 83.3-100), specificity of 65.22% (95% CI: 51.5-79), and negative predictive value of 93.75% (95% CI: 85.4-100) 4. The AUC was 0.79 (95% CI: 0.681-0.897).
UK-ChiMES Scores
Recent pediatric data from Germany showed the UK-ChiMES pre-lumbar puncture score demonstrated sensitivity of 84.6% and specificity of 86.3%, while the post-lumbar puncture score showed sensitivity of 76.9% and specificity of 92.7% 5.
Enhancing Prediction with Biomarkers
The BMS combined with additional biomarkers can achieve 100% negative predictive value 2:
- BMS + CSF lactate ≥2 mmol/L: NPV 100% (95% CI: 94.6-100)
- BMS + blood procalcitonin ≥0.29 µg/L: NPV 97.9% (95% CI: 92.5-99.7)
- BMS + blood CRP ≥24 mg/L: NPV 98.9% (95% CI: 96.1-99.9)
Important Caveats
These scores should NOT be used to determine whether to initiate antimicrobial therapy in individual patients 6. The 2004 Infectious Diseases Society of America guidelines emphasize that clinical judgment remains paramount 6.
Key pitfall: While prediction scores show high negative predictive values, they are screening tools to support—not replace—clinical assessment. When bacterial meningitis is suspected based on clinical presentation (altered consciousness, immunocompromise, CNS disease history, new seizure, papilledema, focal neurologic deficits), empirical antibiotics should be administered immediately after obtaining blood cultures and CSF, regardless of score 6.
The BMS performs less reliably in neonates and should be applied cautiously in this population 3.